Isotretinoin treatment for folliculitis decalvans: A retrospective case-series study
International Journal of Dermatology Jan 10, 2018
Aksoy B, et al. - As a part of this trial, the most effective dose and duration of oral isotretinoin monotherapy were evaluated by the researchers for achieving remission in folliculitis decalvans (FD) patients. In maximum patients, complete response was obtained due to oral isotretinoin monotherapy. Hence, oral isotretinoin ≥0.4 mg/kg/day was recommended for ≥3 months to minimize the tendency of relapse. Oral isotretinoin monotherapy was possibly regarded as a promising therapeutic alternative for FD, for which additional trials were warranted.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries